⌘K
t
Inspiration Healthcare Group plc announced on 02 August 2024 that its Nominated Adviser and Broker is now Panmure Liberum Limited. This change follows the completion of an all-share merger between Liberum Capital Limited and Panmure Gordon Group Limited.
| Date | 2 Aug 2024 |
| Time | 07:00:01 |
| Category | Miscellaneous |
| ID | 8546Y |
2 August 2024
Inspiration Healthcare Group plc
(the "Company")
Nominated Adviser and Broker
Inspiration Healthcare Group plc announces that following the completion of the all-share merger between Liberum Capital Limited and Panmure Gordon Group Limited, the Company's Nominated Adviser and Broker is Panmure Liberum Limited.
For further information, please contact:
|
Inspiration Healthcare Group plc |
Tel: +44 (0)330 175 0000 |
|||
|
Roy Davis, Executive Chair and Interim Chief Executive Officer Alan Olby, Chief Financial Officer |
|
|||
|
|
|
|||
|
Panmure Liberum Limited (Nominated Adviser & Broker) |
Tel: +44 (0)20 3100 2000 |
|||
|
Richard Lindley Will King Joshua Borlant |
|
|||
|
|
|
|||
|
Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com |
|||
|
Anna Dunphy |
Mob: +44 (0) 7876 741 001 |
|||
|
Stephanie Cuthbert |
Mob: +44 (0) 7796 794 663 |
|||
|
Louis Ashe-Jepson |
Mob: +44 (0) 7747 515 393 |
|||
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.
The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and from its facility in Hailsham, East Sussex, and in the USA from its facility in Melbourne, Florida.
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com